<VariationArchive VariationID="1375896" VariationName="NM_003849.4(SUCLG1):c.169_170del (p.Lys57fs)" VariationType="Deletion" Accession="VCV001375896" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1470282" VariationID="1375896">
      <GeneList>
        <Gene Symbol="SUCLG1" FullName="succinate-CoA ligase GDP/ADP-forming subunit alpha" GeneID="8802" HGNC_ID="HGNC:11449" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="84423528" stop="84459280" display_start="84423528" display_stop="84459280" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="84650646" stop="84686585" display_start="84650646" display_stop="84686585" Strand="-" />
          </Location>
          <OMIM>611224</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003849.4(SUCLG1):c.169_170del (p.Lys57fs)</Name>
      <CanonicalSPDI>NC_000002.12:84449679:TTT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="84449680" stop="84449681" display_start="84449680" display_stop="84449681" variantLength="2" positionVCF="84449679" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="84676804" stop="84676805" display_start="84676804" display_stop="84676805" variantLength="2" positionVCF="84676803" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K57fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.84676805_84676806del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.84676805_84676806del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.84449681_84449682del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.84449681_84449682del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016755.1" sequenceAccession="NG_016755" sequenceVersion="1" change="g.14782_14783del">
            <Expression>NG_016755.1:g.14782_14783del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003849.4" sequenceAccession="NM_003849" sequenceVersion="4" change="c.169_170del" MANESelect="true">
            <Expression>NM_003849.4:c.169_170del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003840.2" sequenceAccession="NP_003840" sequenceVersion="2" change="p.Lys57fs">
            <Expression>NP_003840.2:p.Lys57fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1672907018" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003849.4(SUCLG1):c.169_170del (p.Lys57fs) AND Mitochondrial DNA depletion syndrome 9" Accession="RCV001902549" Version="3">
        <ClassifiedConditionList TraitSetID="261">
          <ClassifiedCondition DB="MedGen" ID="C3151476">Mitochondrial DNA depletion syndrome 9</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20693550</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="261" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2450" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)</ElementValue>
                <XRef ID="Mitochondrial+DNA+depletion+syndrome+9+%28encephalomyopathic+with+methylmalonic+aciduria%29/8899" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mitochondrial DNA depletion syndrome 9</ElementValue>
                <XRef ID="MONDO:0009504" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MTDPS9</ElementValue>
                <XRef Type="MIM" ID="245400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SUCLG1-related mitochondrial DNA (mtDNA) depletion syndrome, encephalomyopathic form with methylmalonic aciduria is characterized in the majority of affected newborns by hypotonia, muscle atrophy, feeding difficulties, and lactic acidosis. Affected infants commonly manifest developmental delay / cognitive impairment, growth retardation / failure to thrive, hepatopathy, sensorineural hearing impairment, dystonia, and hypertonia. Notable findings in some affected individuals include hypertrophic cardiomyopathy, epilepsy, myoclonus, microcephaly, sleep disturbance, rhabdomyolysis, contractures, hypothermia, and/or hypoglycemia. Life span is shortened, with median survival of 20 months.</Attribute>
                <XRef ID="NBK425223" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3163" />
                <XRef ID="3163" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28358460</ID>
                <ID Source="BookShelf">NBK425223</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="17" DB="Orphanet" />
              <XRef ID="C3151476" DB="MedGen" />
              <XRef ID="MONDO:0009504" DB="MONDO" />
              <XRef Type="MIM" ID="245400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4161089" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="2016437|MedGen:C3151476" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002147409" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20693550</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys57Aspfs*45) in the SUCLG1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SUCLG1 are known to be pathogenic (PMID: 20693550). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SUCLG1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1375896). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SUCLG1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.84676804_84676805del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3151476" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4161089" TraitType="Disease" MappingType="XRef" MappingValue="C3151476" MappingRef="MedGen">
        <MedGen CUI="C3151476" Name="Mitochondrial DNA depletion syndrome 9" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

